boron/neoplasms

FIELD OF THE INVENTION The present invention relates to a boron drug of boron neutron capture therapy (BNCT) for treating liver cancer, and particularly to a new use of using boric acid as the boron drug of BNCT for treating liver cancer. BACKGROUND OF THE INVENTION Using the boron neutron capture

CROSS-REFERENCE TO RELATED APPLICATION This application claims the priority under 35 USC 35 119(e) of U.S. Provisional Application Ser. No. 61/712,710 filed Oct. 11, 2012 which included by reference herein. BACKGROUND 1. Technical Field The embodiments herein generally relate to a cancer treatment

BACKGROUND 1. Field of the Disclosure The present disclosure relates to novel 4-hydroxytamoxifen and endoxifen prodrugs and the synthesis of the same. Further, the present disclosure teaches the utilization of the novel 4-hydroxytamoxifen and endoxifen prodrugs in a treatment for breast cancer. The

BACKGROUND OF THE INVENTION A. DNCT and its Prior Uses The goal of cancer therapy is to achieve a degree of selectivity that spares normal cells and destroys all malignant ones, since even a small number of remaining malignant cells can lead to recurrence, metastasis, and death. A two-component or

The goal of cancer therapy is to achieve a degree of selectivity that spares normal cells and destroys all malignant ones, since even a small number of remaining malignant cells can lead to recurrence, metastasis, and death. A two-component or binary system comprised of constituents that alone are

FIELD OF THE INVENTION The invention herein is directed to chiral specific boron-containing compounds, such as boronate, boronate esters, boranamines, boranediamines, boranamine thioesters, and boronic mono/di-thioesters, as anti-cancer or anti-amyloidosis agents, as well as their compositions,

TECHNICAL FIELD The present invention relates to a PEG lipid derivative useful as a drug carrier that selectively accumulates in a tumor tissue and delivering boron, and a molecular assembly using the same. BACKGROUND ART Boron neutron capture therapy (hereinafter, also referred to as "BNCT") for

FIELD OF THE INVENTION The present invention relates to the use of boron-containing agents in boron neutron capture therapy killing of target cells. More particularly, this invention relates to boron neutron capture enhancement of fast neutron radiation therapy. BACKGROUND OF THE INVENTION Shortly

TECHNICAL FIELD The present invention relates generally to pharmaceuticals, and more particularly relates to novel pharmaceutical agents in the form of boron heterocycle steroid mimics. The invention additionally relates to pharmaceutical compositions containing a compound of the invention, and to

TECHNICAL FIELD The present invention relates generally to pharmaceuticals, and more particularly relates to novel pharmaceutical agents in the form of boron heterocycle steroid mimics. The invention additionally relates to pharmaceutical compositions containing a compound of the invention, and to

TECHNICAL FIELD This invention pertains to boron-containing porphyrin compounds, and their uses in fields including boron neutron capture therapy of tumors, radiotherapy of tumors, photodynamic therapy of tumors and other diseased tissue, imaging tissues, and inactivation of bacteria and

FIELD OF THE INVENTION The present invention relates generally to a new method for the improvement of radiation therapy of malignant tumors. BACKGROUND OF THE INVENTION Typically, a patient with a malignant tumor undergoes preliminary therapy to greatly reduce the body burden of the malignant cells.

SUMMARY OF THE INVENTION This invention relates to methods for detecting and treating abnormal tissue growth, such as benign and malignant tumors in living beings including, but not limited to the use of drug units formed of monoclonal antibodies containing or combined with units or small quantities

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to improved methods for targeting boron atoms to tumor cells for effecting boron neutron capture therapy (BNCT). BNCT is a binary system designed to deliver ionizing radiation to tumor cells by neutron irradiation of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to improved methods for targeting boron atoms to tumor cells for effecting boron neutron capture therapy (BNCT). BNCT is a binary system designed to deliver ionizing radiation to tumor cells by neutron irradiation of